S-13, Pre14-A, RS, Paid Promos, Insider Sells, Backdoor Acquisitions
S-13:
Near future dilution
$75,000,000 new notes w/ possible limited or no maturity
".....in one or more offerings up to a total aggregate offering price of $75,000,000 on terms to be determined at the time of sale.....maturity, if applicable; "
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11311147 ;
Pre 14-A:
Reverse Split + AS Increase
"To approve an amendment to the Company's Amended Articles of Incorporation to implement one or more Reverse Stock Splits of the Company's common stock at an aggregate ratio of not less than one-for-five and not more than one-for-twenty, within the discretion of the Board of Directors, at any time or from time-to-time prior to July [__], 2017;"
"To approve an amendment to the Company's Amended Articles of Incorporation to increase the authorized number of shares of common stock and preferred stock to 950,000,000 and 50,000,000, respectively"
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11311033 ;
Vote for the AS increase and RS will be very soon
AS is maxed. Issued warrants and CD notes that mature soon need to be able to convert.
"As of March 24, 2016, the number of shares of the Registrant's Common Stock outstanding was 463,036,181, which assumes the conversion of 100 shares of Series A Preferred Stock, convertible at any time into 100 shares of Common Stock, 16,150,000 shares of Series B Preferred Stock, convertible into 86,956,857 shares of Common Stock, and 32,276,008 shares of Common Stock issuable upon the exercise of all of our outstanding warrants."
http://www.otcmarkets.com/stock/TRTC/profile ;
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11286074 ;
Backdoor Acquisition
Therapeutics Medical LLC
On March 10, 2016, the Company entered into an Asset Purchase Agreement (the "Purchase Agreement") with Therapeutics Medical, LLC (the "Seller"), pursuant to which the Company acquired from the Seller certain assets (the "Assets") related to a business engaged in the research, development, and marketing of nutraceutical supplements. The Purchase Agreement provides that the Company will issue a Convertible Promissory Note (the "Convertible Promissory Note") due September 10, 2017, to the Seller in the principal amount of $1.25 million for the purchase of the Assets. The Convertible Promissory Note accrues interest at the rate of one percent per annum, and is convertible into shares of the Company's common stock at a conversion price equal to 90% of the average of the lowest three (3) volume-weighted average prices of one share of common stock for the five (5) consecutive trading days prior to the conversion date.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11286074 ;
"Michael James, CEO of NRTI & CFO for TRTC, quietly and secretively created this new entity, Therapeutics Medical, LLC, that TRTC is now acquiring through this backdoor deal to get ahold of NRTI's entire CBD program, without involving or fairly compensating NRTI or its shareholders. This scheme was well planned out and they have tried to keep it hidden until it was finalized. "
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=121791990 ;
Insider sells
15 Insider sells this month so far...
VANDEVREDE KEN Officer 04/20/2016 Sell direct 50,000 0.4618 472,071
ALMSTEIER AMY Director 04/19/2016 Sell direct 226,799 0.5626 769,279
NAHASS MICHAEL Officer 04/18/2016 Sell direct 300,000 0.4825 3100796
NAHASS MICHAEL Officer 04/15/2016 Sell direct 100,000 0.4825 3400796
VANDEVREDE MIKE Director 04/12/2016 Sell direct 100,000 0.3726 1,056,944
VANDEVREDE STEVE Director 04/11/2016 Sell direct 150,000 0.3475 669,444
VANDEVREDE STEVE Director 04/08/2016 Sell direct 92,500 0.3782 819,444
NAHASS MICHAEL Officer 04/07/2016 Sell direct 100,000 0.4040 3,500,796
VANDEVREDE KEN Officer 04/06/2016 Sell direct 25,000 0.3500 522,071
NAHASS MICHAEL Officer 04/06/2016 Sell direct 200,000 0.3690 3,600,796
VANDEVREDE KEN Officer 04/05/2016 Sell direct 25,000 0.3105 547,071
ALMSTEIER AMY Officer 04/04/2016 Sell direct 303,427 0.2953 996,078
NAHASS MICHAEL Director 04/04/2016 Sell direct 400,000 0.3060 3,800,796
VANDEVREDE KEN Officer 04/04/2016 Sell direct 125,000 0.2708 572,071
ALMSTEIER AMY Officer 04/01/2016 Sell direct 274,800 0.2701 1,299,505
Read more:http://www.nasdaq.com/symbol/trtc/insider-trades#ixzz45rauELu1 ;
New Paid Promotions
Disclaimer: "....All companies profiled on this website pay cash, unrestricted stock or restricted stock..."
4/18/2016 TRTC Small Cap Voice
4/12/2016 TRTC Small Cap Voice
4/10/2016 TRTC Promotion Stock Secrets
http://stockpromoters.com/news-letters.aspx?symbol=TRTC ;
http://smallcapvoice.com/blog/disclaimer/
Short Interest
Apr 14, 2016 1,432,586 shares short
Only 1.4m shares short
http://www.otcmarkets.com/stock/TRTC/short-sales
News 
Market Data 
Discover 
AI
